Day

December 15, 2020
EU-PEARL is set to transform the way clinical trials are conducted by developing tools and methodologies to create Integrated Research Platforms (IRPs). This novel approach has the potential to make drug development processes more efficient and faster. A pivotal element is the master protocol, which is still a relatively novel concept. Its implications in critical...
Read More
At the recent stakeholder workshop, it was clear that EU-PEARL is focussed on ensuring the clinical trials of the future are going to be fit for purpose for all stakeholders to draw robust conclusions from them. This is an exciting time to be involved in clinical trial design; understanding what the benefits and risks of...
Read More

Signup to stay informed